Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04025125 · ClinicalTrials.gov registry record
Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,039
- Enrollment target
NCT04025125: Completed study, sponsored by Duke University.
NCT04025125 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,039 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04025125 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,039 participants
- Enrollment target
Study Summary
The goal of this research is to generate evidence-based recommendations for the management of cardiovascular disease (CVD) risk in People Living with HIV (PLWH). The overall objectives of this application are to demonstrate the effect of cardiology referral on CVD outcomes in a racially/ethnically diverse cohort of PLWH, and to generate qualitative data with which to develop of a future intervention. Our central hypothesis is that cardiology referral reduces incident CVD events in underrepresented racial/ethnic minority (URM) populations with HIV compared to nonreferral. Our hypothesis has been formulated based on our own work identifying that race and provider specialty impact cardiovascular risk management. The rationale for our research is that, once it is known how URM populations with HIV access cardiology referrals, and the impact on CVD outcomes, an intervention can be appropriately designed resulting in new and innovative approaches to the management of URM PLWH at elevated CVD risk.
Primary Outcome
A binary variable, with 'yes' defined if there is documented evidence that a ambulatory visit was made with a cardiologist after becoming eligible by CVD risk score, and 'no' otherwise. Patients were followed from the date when they met eligibility criteria to the date of first encounter with a cardiology specialist or through a maximum of 5 years from their eligibility date. Follow-up was censored early at the end of data collection (December 31, 2020), or 6 months after the patient's last amb
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,039 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2020-12-31 |
What the finished NCT04025125 record still lists
NCT04025125 is an observational study that tracks outcomes without assigning an intervention. Its 2,039 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04025125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04025125 about?
NCT04025125 is a clinical study titled "Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)". The goal of this research is to generate evidence-based recommendations for the management of cardiovascular disease (CVD) risk in People Living with HIV (PLWH). The overall objectives of this application are to demonstrate the effect of cardiology referral on CVD outcomes in a racially/ethnically d...
What is the current status of trial NCT04025125?
This trial is currently completed. The enrollment target is 2,039 participants. The study started on 2014-01-01. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT04025125?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI